30-Day Outcomes of Real-World Elective Carotid Stenosis Treatment Using a Dual-Layer Micromesh Stent (ROADSAVER Study)
Language English Country United States Media print-electronic
Document type Journal Article, Observational Study, Multicenter Study
PubMed
40107985
PubMed Central
PMC11958397
DOI
10.1007/s00270-025-04003-z
PII: 10.1007/s00270-025-04003-z
Knihovny.cz E-resources
- Keywords
- Carotid artery disease, Carotid artery revascularization, Carotid artery stenting, Cerebrovascular embolic protection, Stroke prevention,
- MeSH
- Stroke epidemiology MeSH
- Middle Aged MeSH
- Humans MeSH
- Prospective Studies MeSH
- Prosthesis Design MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Carotid Stenosis * surgery diagnostic imaging mortality therapy MeSH
- Stents * MeSH
- Treatment Outcome MeSH
- Check Tag
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Multicenter Study MeSH
- Observational Study MeSH
- Geographicals
- Europe MeSH
PURPOSE: Carotid artery stenting with single-layer stents carries a risk of periprocedural cerebral embolization compared to carotid endarterectomy. Dual-layer micromesh stents were designed for improved plaque coverage and sustained embolic protection. This analysis aimed to confirm the Roadsaver dual-layer micromesh stent safety in a real-world carotid artery stenting cohort. MATERIALS AND METHODS: ROADSAVER was a prospective, single-arm, multicenter, observational study. Patients with carotid artery stenosis, eligible for elective stenting, were enrolled at 52 sites across 13 European countries. All procedures followed standard practice. The primary outcome was the 30-day major adverse event rate, defined as the cumulative incidence of any death or stroke. All deaths, strokes, and carotid artery revascularizations were independently adjudicated. RESULTS: In total, 1965 patients were analysed (mean age 70.6 ± 8.8 years). Cerebral ischaemia symptoms were present in 49.4% of participants. Radial/ulnar access was used in 26.3% of cases and embolic protection in 63.8%. The 30-day major adverse event incidence was 2.2% (1.6% in asymptomatic and 2.8% in symptomatic patients), with any stroke at 1.9%, any death at 0.8%, and stroke-related death at 0.5%. Predictors of higher 30-day major adverse event risk, identified through multivariable modelling, included residual stenosis ≥ 30%, thromboembolic venous disease, previous myocardial infarction, age ≥ 75 years, family history of atherosclerosis, non-insulin-dependent diabetes mellitus, symptomatic carotid stenosis, and stent length. CONCLUSION: Dual-layer micromesh carotid artery stenting is safe, with a low 30-day major adverse event incidence in real-world asymptomatic and symptomatic patients, supporting the sustained embolic protection design concept. LEVEL OF EVIDENCE: Level 2, observational study (with dramatic effect).
Angiology and Vascular Surgery Department Hospital Universitari Son Espases Palma Spain
Cardioangiologisches Centrum Bethanien at Agaplesion Bethanien Hospital Frankfurt Germany
Center of Radiology Clinical Centre of Vojvodina Novi Sad Serbia
Centre de Cardiologie et d'Exploration de la Côte Basque Bayonne France
Centre of Vasculare Medicine Elblandklinikum Radebeul Radebeul Germany
Clinic of Vascular and Internal Diseases Dr Jan Biziel University Hospital No 2 Bydgoszcz Poland
Department of Interventional Cardiology Kardiocentrum Nitra s r o Nitra Slovakia
Department of Interventional Neuroradiology Hospital Clinic of Barcelona Barcelona Spain
Department of Interventional Radiology CINRE s r o Bratislava Slovakia
Department of Medical Imaging AZ Groeninge Kortrijk Belgium
Department of Radiology and Neuroradiology Klinikum Passau Passau Germany
Department of Radiology Military University Hospital Prague Prague Czech Republic
Department of Radiology Riga Stradiņš University Riga Latvia
Department of Radiology St Antonius Hospital Nieuwegein The Netherlands
Department of Radiology University Hospital Ostrava Ostrava Czech Republic
Department of Vascular and Thoracic Surgery Imelda Hospital Bonheiden Bonheiden Belgium
Department of Vascular and Thoracic Surgery O L 5 Aalst Aalst Belgium
Department of Vascular Surgery and Angiology Brothers of Mercy St John of God Hospital Kraków Poland
Department of Vascular Surgery AZ Sint Blasius Dendermonde Belgium
Department of Vascular Surgery St Franziskus Hospital Münster Germany
Department of Vascular Surgery University Hospitals Leuven Leuven Belgium
Diagnostische Radiologie Neuroradiologie SRH Klinikum Karlsbad Langensteinbach Karlsbad Germany
Division of Invasive Cardiology Department of Internal Medicine University of Szeged Szeged Hungary
Division on Endovascular Therapy Department of Vascular Surgery John Paul 2 Hospital Kraków Poland
Faculty of Medicine Riga Stradiņš University Riga Latvia
Faculty of Medicine University of Ostrava Ostrava Czech Republic
Fuerst Stirum Hospital Cardiology and Vascular Medicine Bruchsal Germany
Infirmerie Protestante de Lyon Caluire et Cuire France
Központi Radiológiai Osztály Markusovszky Egyetemi Oktatókórház Szombathely Szombathely Hungary
Neuroendovascular Division Department of Neurosurgery University of Pécs Pécs Hungary
Neuroradiology Department Hospital Universitario A Coruña A Coruña Spain
Neurosurgery Clinic University of Szeged Hospital Szeged Hungary
Neurovascular Unit Moritz Kaposi Teaching Hospital Kaposvár Hungary
Servicio de Angiología y Cirugía Vascular Hospital Universitario de Toledo Toledo Spain
SRH Zentralklinikum Suhl Klinik Für Innere Medizin 1 Suhl Germany
See more in PubMed
Eckstein HH, Kuhnl A, Berkefeld J, Lawall H, Storck M, Sander D. Diagnosis, treatment and follow-up in extracranial carotid stenosis. Dtsch Arztebl Int. 2020. 10.3238/arztebl.2020.0801. PubMed PMC
Naylor R, Rantner B, Ancetti S, et al. Editor’s choice—European society for vascular surgery (ESVS) 2023 clinical practice guidelines on the management of atherosclerotic carotid and vertebral artery disease. Eur J Vasc Endovasc Surg. 2023. 10.1016/j.ejvs.2022.04.011. PubMed
Muller MD, Lyrer P, Brown MM, Bonati LH. Carotid artery stenting versus endarterectomy for treatment of carotid artery stenosis. Cochrane Database Syst Rev. 2020. 10.1002/14651858.CD000515.pub5. PubMed PMC
Stabile E, de Donato G, Musialek P, et al. Use of dual-layered stents in endovascular treatment of extracranial stenosis of the internal carotid artery: results of a patient-based meta-analysis of 4 clinical studies. JACC Cardiovasc Interv. 2018. 10.1016/j.jcin.2018.06.047. PubMed
Sannino A, Giugliano G, Toscano E, et al. Double layered stents for carotid angioplasty: a meta-analysis of available clinical data. Catheter Cardiovasc Interv. 2018. 10.1002/ccd.27421. PubMed
Montorsi P, Caputi L, Galli S, et al. Carotid Wallstent versus Roadsaver stent and distal versus proximal protection on cerebral microembolization during carotid artery stenting. JACC Cardiovasc Interv. 2020. 10.1016/j.jcin.2019.09.007. PubMed
Kahlberg A, Bilman V, Ardita V, et al. Contemporary results of carotid artery stenting using low-profile dual-metal layer nitinol micromesh stents in relation to single-layer carotid stents. J Endovasc Ther. 2021. 10.1177/15266028211025046. PubMed
Mazzaccaro D, Giannetta M, Fancoli F, Righini P, Nano G. Endovascular treatment of extracranial carotid artery stenosis using a dual-layer micromesh stents: a systematic review. Expert Rev Med Devices. 2021. 10.1080/17434440.2021.1927707. PubMed
Mazurek A, Malinowski K, Rosenfield K, et al. Clinical outcomes of second- versus first-generation carotid stents: a systematic review and meta-analysis. J Clin Med. 2022. 10.3390/jcm11164819. PubMed PMC
Kedev S, Muller-Hulsbeck S, Langhoff R. Real-world study of a dual-layer micromesh stent in elective treatment of symptomatic and asymptomatic carotid artery stenosis (ROADSAVER). Cardiovasc Intervent Radiol. 2022. 10.1007/s00270-021-03051-5. PubMed PMC
Barnett HJM, Taylor DW, Haynes RB, et al. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med. 1991. 10.1056/NEJM199108153250701. PubMed
Silver FL, Mackey A, Clark WM, et al. Safety of stenting and endarterectomy by symptomatic status in the carotid revascularization endarterectomy versus stenting trial (CREST). Stroke. 2011. 10.1161/STROKEAHA.110.610212. PubMed PMC
Brott TG, Howard G, Roubin GS, et al. Long-term results of stenting versus endarterectomy for carotid-artery stenosis. N Engl J Med. 2016. 10.1056/NEJMoa1505215. PubMed PMC
International Carotid Stenting Study investigators; Ederle J, Dobson J et al. 2010 Carotid artery stenting compared with endarterectomy in patients with symptomatic carotid stenosis (International Carotid Stenting Study) an interim analysis of a randomised controlled trial. Lancet. 10.1016/S0140-6736(10)60239-5 PubMed PMC
Halliday A, Bulbulia R, Bonati LH, et al. Second asymptomatic carotid surgery trial (ACST-2): a randomised comparison of carotid artery stenting versus carotid endarterectomy. Lancet. 2021. 10.1016/S0140-6736(21)01910-3. PubMed PMC
Pini R, Faggioli G, Paraskevas KI, Campana F, Sufali G, Rocchi C. Carotid artery stenting with double-layer stent: a systematic review and meta-analysis. J Endovasc Ther. 2024. 10.1177/15266028221126940. PubMed PMC
Ruffino MA, Faletti R, Bergamasco L, Fonio P, Righi D. Incidence of new ischaemic brain lesions after carotid artery stenting with the micromesh Roadsaver carotid artery Stent: a prospective single-centre study. Cardiovasc Intervent Radiol. 2016. 10.1007/s00270-016-1454-7. PubMed
Ruffino MA, Faletti R, Fronda M, et al. Early embolization after carotid artery stenting with mesh-covered atent: role of diffusion-weighted magnetic resonance imaging as pre-procedural predictor and discriminant between intra- and post-procedural events. Cardiovasc Intervent Radiol. 2019. 10.1007/s00270-019-02173-1. PubMed
Squizzato F, Piazza M, Forcella E, et al. Impact of carotid stent design on embolic filter debris load during carotid artery stenting. Stroke. 2023. 10.1161/STROKEAHA.123.043117. PubMed
Howard G, Roubin GS, Jansen O, et al. Association between age and risk of stroke or death from carotid endarterectomy and carotid stenting: a meta-analysis of pooled patient data from four randomised trials. Lancet. 2016. 10.1016/S0140-6736(15)01309-4. PubMed
Casana R, Malloggi C, Odero A Jr, et al. Is diabetes a marker of higher risk after carotid revascularization? Experience from a single centre. Diab Vasc Dis Res. 2018. 10.1177/1479164118769530. PubMed
Wimmer NJ, Yeh RW, Cutlip DE, Mauri L. Risk prediction for adverse events after carotid artery stenting in higher surgical risk patients. Stroke. 2012. 10.1161/STROKEAHA.112.673194. PubMed PMC
Colussi G, Zuttion F, Bais B, et al. Pre-procedural statin use is associated with improved long-term survival and reduced major cardiovascular events in patients undergoing carotid artery stenting: a retrospective study. J Clin Med. 2018. 10.3390/jcm7090286. PubMed PMC